These findings support a hypothesis whereby gains in NAALADL2 and TBL1XR1 concomitantly bring about mRNA expression changes which support an aggressive pro-proliferative phenotype in primary prostate cancer. This evidence concerns the gene TBL1XR1 and prostate carcinoma.